Poll results reveal overwhelming disagreement regarding the decision, with a small number saying it was a good move
Over-the-counter medicines containing codeine will be upscheduled to prescription-only from 1 February 2018, the TGA announced five days before Christmas.
We asked what you thought about the decision: was it a good decision? A bad one? What will the impact be on pharmacists, on patients?
Respondents could vote for more than one option.
Our poll results show readers have two main thoughts about the codeine decision:
- Alternatives such as MedsASSIST should have been made mandatory – 62% (365 votes); and
- It will put more strain on the healthcare system – 62% (364 votes).
This was followed by concerns for patients and also financial ones, with 47% (275 votes) saying “it will negatively affect people with acute pain” and 36% (209 votes) saying “it will negatively affect sales”.
Another 30% said “it’s a bad idea” and 26% (150 votes) believed “it will make our job harder”.
On the other hand, 26% (155 votes) said “it will better help people with addiction issues” and 20% (115 votes) believed “it’s the safest decision to protect people’s health”.
The majority of results reflect the responses of pharmacy organisations after the decision was announced.
A spokesperson for the Pharmacy Guild told the AJP that the TGA’s decision will disadvantage many people who currently use them appropriately.
“The demand for codeine products will remain, and there is no evidence that making codeine products prescription-only will reduce demand or abuse,” the spokesperson said.
ASMI also expressed disappointment that more targeted measures for codeine-containing medicines currently available OTC were not tried first.
And PSA president Joe Demarte said the decision was a missed opportunity to ensure Quality Use of Medicines.
Overall there was consensus and support among pharmacy organisations and pharmacists for the implementation of a national real-time recording and reporting system.